🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07568704
Recruiting Observational

Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA Images

NCT07568704 · tracked via the Priya Life Science USA tracker
Sponsor
Intalight, Inc
Phase
Observational
Started
2026-03-25
Last updated
2026-05-06

Condition(s) studied

Retina Pathology

Investigational drug(s) / intervention(s)

Dream OCT

Dream OCT: This study employs the Dream OCT to image the eyes of patients with retina pathology

Study summary

The goal of this study is to evaluate the image quality and clinical utility of the OCTA images from the VG200D OCT device (investigational device) compared against the FA and ICGA images from the UWF Optos California (CA) device. Image assessment will be conducted by three expert image graders and involve the assessment of the images based on both image quality and clinical utility. Evidence for substantial equivalence will be obtained through establishing similar image evaluation results across the devices based on image quality and clinical utility.

Eligibility

Sex
ALL
Min age
22 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Subjects 22 years of age or older on the date of informed consent * Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent * BCVA 20/400 or better in the study eye * Diagnosis of retinal associated pathology by investigator with the need to have an FA and/or ICGA performed in at least one eye Exclusion Criteria: * Subjects unable to tolerate ophthalmic imaging * Subjects not able to obtain acceptable OCT images due to ocular media opacity or other reasons * Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Retina Consultants of Texas Houston Texas Recruiting

More Intalight, Inc trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07568704 on ClinicalTrials.gov ↗ ← All trials in the USA